FDA NDC Directory · JSON-LD · Markdown

NYSTATIN

NDC 70771-1585 · HUMAN PRESCRIPTION DRUG · POWDER

Generic namenystatin
Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA208581
Dosage form / routePOWDER · TOPICAL
Active ingredientsNYSTATIN (100000 [USP'U]/g)
Marketing started20211006
Package count3

External sources

Source: openFDA. Public-domain (CC0).